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Abstract
Background: IgG4-related disease is a novel disease entity characterized by elevated serum IgG4 and tissue
infiltration by IgG4-positive plasma cells. Typical renal pathology is tubulointerstitial nephritis with storiform fibrosis,
although the co-existence of various glomerular lesions has been described. Here, we present the first report of a
case of IgG4-related kidney disease and membranoproliferative glomerulonephritis showing the discrepancy in IgG
subclasses between the kidney interstitium and glomeruli.
Case presentation: A 70-year-old Japanese woman was diagnosed with membranoproliferative glomerulonephritis
and focal tubulointerstitial nephritis with IgG4-positive plasma cells. Immunofluorescence studies revealed
predominant deposition of IgG3 and IgG2, but not IgG4 in the glomeruli. We administered oral prednisolone at
30 mg/day, and the abnormalities in urine and blood tests gradually resolved.
Conclusion: In this case, different patterns of IgG subclasses detected in the glomeruli and interstitial plasma cells
suggest overlapping immunologic abnormalities. The favorable clinical course in our patient suggests that steroid
therapy is promising in cases of IgG4-related kidney disease accompanied by glomerulonephritis.
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Background
IgG4-related disease (IgG4-RD) is a novel disease entity
characterized by elevated serum IgG4 and tissue infiltra-
tion by IgG4-positive plasma cells. Renal involvement is
often observed in this disease, and the typical histopatho-
logical findings are tubulointerstitial nephritis with abun-
dant IgG4-positive plasma cells and storiform fibrosis and
sclerosis [1]. With regard to the glomerular lesions, mem-
branous nephropathy is the most common type, and can
develop with and without tubulointerstitial nephritis
[2–4]. However, some other forms of glomerulonephritis,
such as mesangial proliferative glomerulonephritis, IgA
nephropathy, Henoch–Schönlein purpura nephritis (IgA
vasculitis), endocapillary proliferative glomerulonephritis,
and membranoproliferative glomerulonephritis (MPGN)
have also been reported [3–8]. In the cases with membran-
ous nephropathy, IgG4 deposition along the glomerular
capillaries was demonstrated [8], suggesting that mem-
branous nephropathy shares the same pathogenesis as sys-
temic serological abnormalities and other types of organ
involvement. However, the interpretation of the pathogen-
esis of other types of glomerulonephritis is still unclear.
Here, we report the case of a patient diagnosed with
IgG4-RD, complicated with MPGN and accompanied by
focal tubulointerstitial nephritis with IgG4-positive
plasma cells. We also investigated IgG subclasses in the
glomeruli, and found predominant deposition of IgG3
and IgG2, but not IgG4.
Case presentation
A 70-year-old Japanese woman with a past history of
bronchial asthma and paroxysmal atrial fibrillation
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was transferred to Kyushu University Hospital because
of leg edema and insidious onset of proteinuria and
microhematuria. She had presented with mild leg
edema 8 months before, and was admitted to another
hospital because of pneumonia. Then heavy protein-
uria was identified. She had a history of polyar-
thralgia, although other symptoms such as skin rash,
hair loss, oral ulcers, and Sicca syndrome were not
evident.
On admission, the patient’s characteristics were: height
144 cm, body weight 38.7 kg, body temperature 36.9 °C,
and blood pressure 120/46 mmHg. Physical examination
revealed normal breath sounds, heart sounds, abdomen
and nervous system, but signs of anemia in the palpebral
conjunctiva and bilateral leg edema were found. Urinaly-
sis revealed proteinuria (2+), and occult blood (2+).
Urinary protein excretion was 2.3 g/day. Complete blood
counts revealed: white blood cells 3050/μL, red blood
cells 252 × 104/μL, hemoglobin 8.2 g/dL, hematocrit
24.3 %, and platelets, 12.9 × 104/μL, with no atypical leu-
kocytes. Serum biochemical analyses revealed: total
protein 6.9 g/dL, serum albumin 3.0 g/dL, blood urea ni-
trogen 33.0 mg/dL, serum creatinine 1.09 mg/dL (eGFR
43.2 mL/min/1.73 m2), sodium 141 mmol/L, potassium
5.1 mmol/L, chloride 115 mmol/L, calcium 8.3 mg/dL,
phosphate 4.9 mg/dL, and C-reactive protein 0.21 mg/
dL. Quantitative immunoglobulin analysis showed: IgG
2407 mg/dL (normal, 872–1815 mg/dL), IgA 114 mg/dL
and IgM 53 mg/dL (59–269 mg/dL), and the additional
measurement of IgG subclasses revealed IgG1 564 mg/
dL (320–748 mg/dL), IgG2 1650 mg/dL (208–754 mg/
dL), IgG3 214 mg/dL (6.6-88.3 mg/dL), and IgG4
1110 mg/dL (4.8–105 mg/dL). Serum levels of C3, C4
and total serum hemolytic activity (CH50) were 58 mg/
dL (71–135 mg/dL), 9 mg/dL (11–34 mg/dL), and 32 U/
mL (31.6–57.6 U/mL), respectively. Although rheuma-
toid factor was increased to 133 IU/mL (<15 IU/mL),
antinuclear antibodies, anti-double-stranded DNA anti-
bodies, anti-U1-ribonucleoprotein antibodies, myeloper-
oxidase anti-neutrophil cytoplasmic antibodies (ANCA),
proteinase 3 ANCA, anti-glomerular basement mem-
brane (GBM) antibodies, anti-Sjögren syndrome related
antigen (SS)-A antibodies, anti-SS-B antibodies, circulat-
ing immune complexes, and cryoglobulins were all nega-
tive. Hepatitis B virus surface antigen, hepatitis C virus
antibodies, and human T-lymphotropic virus 1 anti-
bodies were negative. T-SPOT.TB assays for the diagno-
sis of latent tuberculosis was also negative. Abdominal
ultrasonography and computed tomography scanning re-
vealed the absence of systemic lymphadenopathy, and
no abnormal findings in the pancreas, salivary glands,
and thyroid gland, although ultrasonography showed mild
enlargement of bilateral kidneys (right 10.3 × 4.4 cm, and
left 10.8 × 4.1 cm).
Percutaneous kidney biopsy was performed on the
12th hospital day to determine the cause of the urinary
abnormalities and kidney dysfunction. Light microscopic
observation revealed global glomerulosclerosis in 1 of 13
glomeruli with mild interstitial edema and inflammation
(Fig. 1a). The infiltrating cells were mainly mononuclear
cells, but occasional eosinophils and a number of plasma
cells were also noted. Storiform interstitial fibrosis was
not evident (Fig. 1b). Twelve non-sclerotic glomeruli
showed uniform changes; moderate to severe mesangial
proliferation, increased mesangial matrix, and mild to
moderate endocapillary hypercellularity. Subendothelial
deposits (Fig. 1c), and double contours of the glomerular
capillaries were also observed (Fig. 1d). No glomerular
crescent was found. Immunofluorescence studies showed
“full-house” staining for IgG (3+), IgA (1+), IgM (1+), C3
(2+), C1q (3+), and fibrinogen (1+) in the glomerular
mesangium and the capillary wall (Fig. 2). Ultrastructural
examination showed focal foot process effacement of the
glomerular epithelial cells, mesangial and subendothelial
electron-dense deposits, and mesangial interposition
(Fig. 3). According to these findings, we confirmed the
pathological diagnosis of MPGN type 1.
Because the patient showed extremely high serum
IgG4, we performed a lip biopsy and found the diffuse
infiltration of IgG4 positive plasma cell in the glandular
area (Fig. 4a and b); thus, the diagnosis of IgG4-RD was
confirmed. Kidney-infiltrating plasma cells also produced
IgG4, suggesting focal and early stage IgG4-related kidney
disease (IgG4-RKD) (Fig. 4c and d). However, additional
immunofluorescence studies revealed predominant depos-
ition of IgG2 and IgG3, negative IgG1, and minimal IgG4
deposition in the glomeruli (Fig. 4e–h).
Although we found discrepancies in IgG subclass
among the glomeruli and kidney interstitium, we treated
this patient as IgG4-RD. Oral prednisolone administra-
tion (initial dose 30 mg/day) was started. The patient
showed decreased urinary protein, and increased serum
albumin and complement levels. In examinations con-
ducted in our outpatient clinic 8 months later, the pa-
tient showed proteinuria (±), hematuria (3+), white
blood cell count 9690/μL, hemoglobin 11.4 g/dL, platelet
count 32.5 × 104/μL, serum albumin 3.9 g/dL, serum cre-
atinine 0.96 mg/dL, C3 99 mg/dL, C4 23 mg/dL, IgG
1002 mg/dL and IgG4 200 mg/dL (Fig. 5).
Discussion
Here, we report the case of a patient diagnosed as IgG4-
RD accompanied by MPGN type 1 with “full-house im-
munofluorescence”. We confirmed the diagnosis of
IgG4-RD with serological tests and a lip biopsy showing
significant infiltration of the glandular area by IgG4-
positive plasma cells. IgG4-positive plasma cells with lit-
tle fibrosis were also found in the kidney interstitium,
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Fig. 2 Immunofluorescence staining for immunoglobulin and complement. Glomerular depositions of IgG (3+), IgA (1+), IgM (1+), C3 (2+), C1q
(3+) and fibrinogen (1+) are evident in the mesangial area and capillary loop
Fig. 1 Light microscopic findings of kidney biopsy. a Kidney tissue showing focal interstitial inflammation and edema without evident storiform
fibrosis. Hematoxylin and eosin (H&E) staining (magnification, × 100). b Interstitial infiltrating cells dominated by mononuclear cells, although
infiltrating eosinophils and plasma cells are also observed. H&E staining (magnification, × 400). c Glomerulus showing mesangial proliferation,
endocapillary hypercellularity, and subendothelial deposits. Periodic acid Schiff staining (magnification, × 400). d Double contours of glomerular
capillaries are frequently observed. Periodic acid silver methenamine staining, (magnification, × 400)
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and the IgG4/IgG ratio exceeded 40 %. We then diag-
nosed IgG4-RKD equivalent to stage A tubulointerstitial
nephritis according to the schema suggested by Yamaguchi
et al. [9]. However, the predominant IgG2/IgG3 deposition
and minimal IgG4 deposition in the glomeruli conflicted
with the systemic serological status, and the pathology of
minor salivary glands and kidney interstitium. In this case,
the most important differential diagnosis was a prolifera-
tive form of lupus nephritis because the patient developed
hypocomplementemia and pancytopenia. However, her
extrarenal symptoms did not suggest systemic lupus ery-
thematosus (SLE), and laboratory data revealed that she
was negative for antinuclear antibodies and anti-DNA
antibodies; thus, ultimately, the patient did not fulfill the
criteria of SLE.
Renal involvement in IgG4-RD, designated IgG4-RKD,
is characterized by increased IgG4-positive plasma cells
in the kidney interstitium, and various degrees of stori-
form fibrosis that can be recognized with methenamine
silver and trichrome stains. Several forms of concurrent
glomerulonephritis have been reported in IgG4-RKD
[3–8]. Membranous nephropathy is the most common,
and predominant IgG4 deposition along the glomerular
capillary has been demonstrated [8], suggesting a common
pathophysiology with systemic IgG4 overexpression and
related cytokine production. However, in patients with
IgG4-RD with other forms of glomerulonephritis, the
common pathophysiology between systemic abnormalities
and glomerular lesions is less apparent. One case of IgG4-
RD and MPGN has been reported previously, but unfortu-
nately, immunofluorescence analysis of IgG subclasses in
the glomeruli was not included [5]. Thus, this is the first
report of a case of IgG4-RKD and MPGN showing the dis-
crepancy in IgG subclasses between the kidney intersti-
tium and glomeruli.
The immunological abnormalities associated with IgG4-
RD have been extensively investigated, and recent studies
suggest an important role of T-helper (Th) 2 cells and
regulatory T cells (Treg) in the development of IgG4-RD.
Müller et al. demonstrated increased interleukin (IL)-4
and IL-5 levels, and upregulated IL-13 mRNA in bile sam-
ples from a patient with IgG4-related cholangitis [10].
Tanaka et al. investigated the expression patterns of cyto-
kines, chemokines, and cytokine receptors in the labial
salivary glands of patients with Mikulicz disease and
Sjögren syndrome, and demonstrated that mRNA levels of
IL-4, IL-5, IL-10, TGF-β, and Foxp3 were upregulated in
Mikulicz disease compared with Sjögren syndrome and
controls [11]. In the present case, predominant deposition
of IgG2 and IgG3, but not IgG4 was found in the glom-
eruli, and immunofluorescence analysis showed that IgG3
deposition predominated. IgG3 is well-known as the typ-
ical “Th1 subclass IgG” and associated with primary
MPGN [12, 13]. In general, Th1 and Th2 cells suppress
each other, and polarization toward a Th1 nephritogenic
immune response is associated with proliferative, cres-
centic forms of glomerulonephritis such as MPGN,
ANCA-associated glomerulonephritis, and anti-GBM anti-
body glomerulonephritis, whereas Th2 activation is found
in membranous nephropathy [12, 14, 15]. The renal path-
ology of the present case revealed co-existence of a Th1-
associated pro-inflammatory response in the glomeruli,
and Th2/Treg-associated changes in the interstitium.
Similar phenomena of overlapping different pathologies
can be found in the exceptional cases of crescentic mem-
branous nephropathy with or without ANCA [16, 17].
Furthermore, in lupus nephritis, co-incidence of class IV
and class V glomerular lesions are often found [18]. Fur-
ther investigations are required to clarify the detailed
mechanisms of the co-existence of two different immune
responses in the same patient.
With regard to the treatment, we initially started low-
dose oral prednisolone (30 mg/day) which was previ-
ously reported for the treatment of IgG4-RKD [3, 8],
Fig. 3 Electron microscopic findings. a Mesangial cell proliferation, mesangial matrix increase and mesangial electron dense deposit, and
mesangial interposition (arrow) are noted. Subepithelial deposits were not found in the sampled glomeruli. b Diffuse foot process effacement and
subendothelial electron dense deposit (arrowhead) are noted
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after we had carefully excluded SLE, cryoglobulinemic
vasculitis, and monoclonal immunoglobulin deposition
disease. Although low-dose steroid monotherapy is not
sufficient for primary MPGN type 1, the patient’s urinary
protein immediately decreased, kidney function was pre-
served, and serum IgG4 levels showed a gradual decline.
The complement levels and complete blood cell counts
also returned to the normal range. In the previous report
of MPGN and IgG4-RKD reported by Morimoto et al.
[5], the patient died of mycoplasma pneumonia and con-
gestive heart failure a few months after the biopsy con-





Fig. 4 Immunohistochemical staining for IgG4 in lip and kidney biopsies. a Immunohistochemical staining for CD138 in a lip biopsy specimen.
b IgG4 staining in the lip using serial section. In the glandular area, diffuse infiltration of IgG4-positive plasma cells is observed, and an IgG4/
CD138 ratio is approximately 85 %. c Immunohistochemical staining for IgG in a kidney biopsy specimen. d IgG4 staining in the kidney using
serial section revealed several foci of IgG4-positive cells in the interstitium. The IgG4/IgG ratio is approximately 90 %. Original magnification,
× 400. e–h Glomeruli showing predominant IgG2 and IgG3 (IgG3 > IgG2) deposition in the mesangial area and capillary loop. Deposition of IgG1
is negative, and IgG4 shows weak and segmental deposition
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the favorable clinical course in our case is promising,
and it is important to collect information on more
cases of IgG4-RKD accompanied by glomeruloneph-
ritis to determine the response of such patients to
steroid therapy.
Conclusions
We have described the case of a patient with IgG4-RD
accompanied by IgG4-related tubulointerstitial nephritis
and MPGN with predominant IgG2 and IgG3 depos-
ition. Different patterns of IgG subclasses detected in
the glomeruli and interstitial plasma cells suggest
overlapping immunologic abnormalities. IgG4-RD is a
novel disease entity and the detailed pathophysiology
is still unknown; thus, this emphasizes the need to
accumulate the details of more cases of IgG4-RKD,
and perform IgG subclass staining extensively if glom-
erular lesions are found in IgG4-RKDs to clarify the
nature of this disease.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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